The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1444516
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP02793811.7
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
22/10/2002
Grant date:
21/07/2010
EP Publication Date:
21/07/2010
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
21/07/2010
EP B1 Publication Date:
21/07/2010
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
20/10/2010
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
21/10/2022
Lapsed By Expiration Date:
22/10/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
21/07/2010
Name:
Amgen, Inc.
Address:
One Amgen Center Drive, THOUSAND OAKS, CA 91320-1799, United States of America (US)
From:
21/07/2010
Name:
The Government of the United States of America, represented by the Secretary, Department of Health and Human Services
Address:
6011 Executive Boulevard, Suite 325, ROCKVILLE, MD 20852-3804, United States of America (US)
From:
21/07/2010
Name:
THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Address:
201 West 7th Street, AUSTIN, TEXAS 78701, United States of America (US)